The NADPARK Study: A Randomized Phase I Trial of NR Supplementation in Parkinson’s Disease (Sponsored Satellite Program)

Speaker(s)

• 

  Charalampos Tzoulis, MD, PhD

  Haukeland University Hospital, University of Bergen, Norway

  Disclosure: Disclosure information not submitted.